P. Piper

发表

Structure of slow-reacting substance of anaphylaxis from guinea-pig lung

H. Morris, G. Taylor, J. Tippins, 1980, Nature.

Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet‐activating factor is mediated by leukotriene C4

A. Stewart, P. Piper, 1986, British journal of pharmacology.

Platelet-activating factor-induced vasoconstriction in rat isolated, perfused hearts: contribution of cyclo-oxygenase and lipoxygenase arachidonic acid metabolites.

A. Stewart, P. Piper, 1986, Pharmacological research communications.

Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay.

J. Zakrzewski, N. Barnes, P. Piper, 1987, British journal of clinical pharmacology.

THE EFFECTS OF GLUCOCORTICOIDS ON THE DISTRIBUTION AND MOBILISATION OF ARACHIDONIC ACID IN FAT CELL GHOSTS

P. Piper, G. Lewis, C. Vigo, 1979, British journal of pharmacology.

PROSTAGLANDIN INACTIVATION IN GUINEA‐PIG LUNG AND ITS INHIBITION

P. Piper, D. Crutchley, 1974, British journal of pharmacology.

Preferential Vasoconstriction to Cysteinyl Leukotrienes in the Human Saphenous Vein Compared With the Internal Mammary Artery: Implications for Graft Performance

M. Yacoub, A. Chester, M. Dashwood, 1994, Circulation.

Leukotrienes and the airways.

P. Piper, 1989, European journal of anaesthesiology.

Pharmacology of leukotrienes.

P. Piper, 1983, British medical bulletin.

Degradation of porstaglandin F2alpha in the human pulmonary circulation.

U. Niederhauser, P. Piper, A. Smith, 1976, Thorax.

Degradation of prostaglandin F 2 a in the human pulmonary circulation

U. Niederhauser, P. Piper, A. Smith, 2022 .

INHIBITION BY GLUCOCORTICOIDS OF PROSTAGLANDIN RELEASE FROM ADIPOSE TISSUE in vitro

J. Chang, P. Piper, G. Lewis, 1977, British journal of pharmacology.

Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man

P. Piper, J. Costello, S. Green, 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

A simple method for the measurement of phospholipase activity

P. Piper, G. Lewis, C. Vigo, 2007 .

Mechanisms of inhibition of phospholipase A2.

P. Piper, G. Lewis, C. Vigo, 1980, Biochemical pharmacology.

Effect of K+ channel‐modulating drugs on the vasoconstrictor responses of leukotrienes C4, D4 and angiotensin II in the guinea‐pig isolated perfused heart

P. Piper, J. McLeod, 1992, British journal of pharmacology.

Antagonism of Bradykinin Bronchoconstriction by Anti-Inflammatory Drugs

J. Vane, P. Piper, 1979 .

Anaphylaxis and the release of active substances in the lungs.

P. Piper, 1977, Pharmacology & therapeutics. Part B: General & systematic pharmacology.

Release of Catecholamines in the Guinea-pig by Substances involved in Anaphylaxis

J. Vane, P. Piper, H. Collier, 1967, Nature.

STIMULATION OF ARACHIDONIC ACID METABOLISM AND GENERATION OF THROMBOXANE A2 BY LEUKOTRIENES B4, C4 AND D4 IN GUINEA‐PIG LUNG in vitro

P. Piper, M. N. Samhoun, 1982, British journal of pharmacology.

Measurement of leukotrienes in asthmatics.

H. Morris, G. Taylor, J. Tippins, 1983, Advances in prostaglandin, thromboxane, and leukotriene research.

Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea‐pig lung parenchyma to histamine, acetylcholine and leukotriene D4

P. Piper, D. Conroy, M. N. Samhoun, 1991, British journal of pharmacology.

hrIL‐8‐Induced Hyperresponsiveness in Guinea Pig Perfused Lungs

J. Westwick, P. Piper, A. Medhurst, 1991, Annals of the New York Academy of Sciences.

Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man.

P. Piper, J. Costello, D. Spencer, 1991, Thorax.

inhaled platelet activating factor in man . the acute bronchoconstrictor response to Participation of the cysteinyl leukotrienes in

P. Piper, J. Costello, D. Spencer, 2022 .

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.

N. Barnes, P. Piper, J. Costello, 1984, Thorax.

Comparison of the actions of leukotriene E4 with those of leukotrienes B4, C4, and D4 on guinea pig lung and ileal smooth muscle in vitro.

P. Piper, M. N. Samhoun, 1983, Advances in prostaglandin, thromboxane, and leukotriene research.

The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin.

M. Peck, T. Williams, P. Piper, 1981, Prostaglandins.

Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis.

P. Greally, J. Price, P. Piper, 1993, Archives of disease in childhood.

The role of arachidonate lipoxygenase in the release of SRS-A from guinea-pig chopped lung.

H. Morris, G. Taylor, J. Tippins, 1980, Prostaglandins.

RELEASE OF MEDIATORS OF ANAPHYLAXIS: INHIBITION OF PROSTAGLANDIN SYNTHESIS AND THE MODIFICATION OF RELEASE OF SLOW REACTING SUBSTANCE OF ANAPHYLAXIS AND HISTAMINE

U. Niederhauser, P. Piper, P. Sirois, 1978, British journal of pharmacology.

Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea‐pig lungs

J. Vane, P. Piper, M. A. Palmer, 1973, British journal of pharmacology.

The role of the epithelium in modulating the responses of guinea‐pig trachea induced by bradykinin in vitro

P. Piper, M. N. Samhoun, A. Bramley, 1990, British journal of pharmacology.

Influence of atherosclerosis on the vascular reactivity of isolated human epicardial coronary arteries to leukotriene C4.

M. Yacoub, A. Chester, M. Dashwood, 1993, Cardioscience.

Effects of leukotrienes C4 and D4 on human isolated saphenous veins.

M. Yacoub, A. Chester, A. Sampson, 1992, British journal of clinical pharmacology.

Effect of ICI 198,615, SK+F 104,353, MK-571 and CGP45715A on cysteinyl leukotriene-induced responses in guinea-pig heart.

P. Piper, J. McLeod, 1991, Prostaglandins.

The actions of leukotrienes C4 and D4 in the porcine renal vascular bed.

P. Piper, A. Stanton, L. J. Mcleod, 1985, Prostaglandins.

Effects of intra-coronary administration of leukotriene D4 in the anaesthetized dog.

S. Greenwald, D. Newman, L. Letts, 1983, Prostaglandins.

Cardiac actions of leukotrienes B4, C4, D4, and E4 in guinea pig and rat in vitro.

L. Letts, P. Piper, 1983, Advances in prostaglandin, thromboxane, and leukotriene research.

Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs

J. Vane, P. Piper, J. R. VANE, 1969, Nature.

Actions of cysteinyl leukotrienes in coronary, femoral and carotid vessels of the pig.

S. Greenwald, D. Newman, L. Letts, 1984, European journal of pharmacology.

Slow reacting substances (leukotrienes): enzymes involved in their biosynthesis.

H. Morris, G. Taylor, J. Tippins, 1982, Proceedings of the National Academy of Sciences of the United States of America.

The evolution and future horizons of research on the metabolism of arachidonic acid by 5-lipoxygenase.

P. Piper, 1984, The Journal of allergy and clinical immunology.

Effects on Smooth Muscle Preparations of Unidentified Vasoactive Peptides from Intestine and Lung

J. Vane, S. Said, P. Piper, 1970, Nature.

THE RELEASE OF PROSTAGLANDINS FROM LUNG AND OTHER TISSUES

J. Vane, P. Piper, 1971, Annals of the New York Academy of Sciences.

Vasoactive intestinal peptide and helodermin inhibit the release of cyclo-oxygenase products induced by leukotriene D4 and bradykinin from guinea-pig perfused lung.

P. Piper, D. Conroy, M. M. Samhoun, 1992, European journal of pharmacology.

Actions of inhaled leukotrienes and their interactions with other allergic mediators

N. Barnes, P. Piper, J. Costello, 1984 .

Antagonism of vasoconstriction induced by platelet‐activating factor in guinea‐pig perfused hearts by selective platelet‐activating factor receptor antagonists

A. Stewart, P. Piper, 1987, British journal of pharmacology.

Inactivation of Prostaglandins by the Lungs

J. Vane, P. Piper, J. Wyllie, 1970, Nature.

The detection of 5-lipoxygenase and cyclo-oxygenase products in sputum of patients with chronic bronchitis and bronchiectasis.

J. Zakrzewski, N. Barnes, P. Piper, 1987, Prostaglandins.

Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery

M. Yacoub, A. Chester, S. Ohri, 1993, Coronary artery disease.

Slow reacting substances (SRSs): the structure identification of SRSs from rat basophil leukaemia (RBL-1) cells.

H. Morris, G. Taylor, J. Tippins, 1980, Prostaglandins.

L-648,051, a novel cysteinyl-leukotriene antagonist is active by the inhaled route in man.

J. Zakrzewski, N. Barnes, D. Sciberras, 1989, British journal of clinical pharmacology.

Reduction in leukotriene B4 generation by bronchoalveolar lavage cells in asthma.

L. Restrick, A. Sampson, P. Piper, 1995, Thorax.

Antagonism ofvasoconstriction induced byplatelet- activating factor ingu.inea-pigperfused hearts by selective platelet-activat

A. Stewart, P. Piper, 1987 .

Role of the VLA-4 integrin in leucocyte recruitment and bronchial hyperresponsiveness in the guinea-pig.

P. Piper, A. Milne, 1995, European journal of pharmacology.

Release of Leukotrienes from Porcine and Human Blood Vessels by Immunological and Nonimmunological Stimuli a

P. Piper, J. Antoniw, A. Stanton, 1988, Annals of the New York Academy of Sciences.

The effect of histamine antagonists on antigen-induced contractions of sensitized human bronchus in vitro [proceedings].

P. Piper, A. Smith, L. Dunlop, 1977, British journal of pharmacology.

Leukotrienes in the sputum and urine of cystic fibrosis children.

C. P. Green, A. Sampson, J. Price, 1990, British journal of clinical pharmacology.

Effects of Interleukin‐5 Inhibition on Antigen‐Induced Airway Hyperresponsiveness and Cell Accumulation in Guinea Pigs

P. Piper, A. Milne, 1994, Annals of the New York Academy of Sciences.

Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.

J. Zakrzewski, N. Barnes, P. Piper, 1987, The American review of respiratory disease.

The action of chemically pure SRS-A on the microcirculation in vivo.

P. Piper, T. Williams, Timothy J. Williams, 1980, Prostaglandins.

Relaxations of guinea-pig isolated trachea induced by platelet-activating factor are epithelial-dependent and are antagonised by WEB 2086.

P. Piper, D. Conroy, M. N. Samhoun, 1990, European journal of pharmacology.

Formation and actions of leukotrienes.

P. Piper, 1984, Physiological reviews.

Pharmacology and Physiology of Leukotrienes and Their Antagonists a

J. Zakrzewski, N. Barnes, P. Piper, 1988, Annals of the New York Academy of Sciences.

Platelet‐activating factor (Paf) antagonist, WEB 2086, protects against Paf‐induced hypotension in Macaca fascicularis

P. Piper, J. Antoniw, A. Stanton, 1989, British journal of pharmacology.

Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects.

A. Sampson, P. Piper, J. Costello, 1992, British journal of clinical pharmacology.

The generation and metabolism of leukotrienes in the ionophore-stimulated blood of normal and asthmatic subjects.

A. Sampson, P. Piper, J. Costello, 1990, Pulmonary pharmacology.

The mechanism of action of leukotrienes C4 and D4 in guinea-pig isolated perfused lung and parenchymal strips of guinea pig, rabbit and rat.

P. Piper, M. N. Samhoun, 1981, Prostaglandins.

THE ACTIONS OF LEUKOTRIENES C4 AND D4 ON GUINEA‐PIG ISOLATED HEARTS

L. Letts, P. Piper, L.G. LETTS, 1982, British journal of pharmacology.

Release of prostaglandins and rabbit aorta contracting substance (RCS) from guinea-pig lung by slow reacting substance of anaphylaxis (SRS-A) [proceedings].

P. Piper, P. Sirois, D. Engineer, 1977, British journal of pharmacology.

The biotransformation in vitro of cysteinyl leukotrienes in blood of normal and asthmatic subjects.

J. Zakrzewski, N. Barnes, A. Sampson, 1989, Prostaglandins.

Actions of leukotrienes in the circulation

L. Letts, P. Piper, A. Stanton, 1984 .

Chapter 3 – Leukotrienes

P. Piper, 1984 .

8 – Biological Actions of the Leukotrienes

P. Piper, 1984 .

Leukotrienes and their Actions in the Lung and Cardiovascular System

L. Letts, P. Piper, M. N. Samhoun, 1983 .

Antagonism by fenamates and like‐acting drugs of bronchoconstriction induced by bradykinin or antigen in the guinea‐pig

P. Piper, H. J. Collier, G. James, 1968, British journal of pharmacology.

The release of prostaglandin-like substances during platelet aggregation and pulmonary microembolism.

J. Vaage, P. Piper, 1975, Acta physiologica Scandinavica.

Leukotrienes and Inflammatory Lung Disease

C. P. Green, J. Price, A. Sampson, 1991, Annals of the New York Academy of Sciences.

The effects of an anti-CD18 antibody (R15.7) in antigen-induced airway hyperresponsiveness (AH) and cell influx in guinea pigs

R. Rothlein, R. Barton, L. Letts, 1991, Agents and Actions.

Release of active substances during anaphylaxis

P. Piper, 1976, Agents and Actions.

THE RELEASE OF PROSTAGLANDINS AND THROMBOXANES FROM GUINEA‐PIG LUNG BY SLOW REACTING SUBSTANCE OF ANAPHYLAXIS, AND ITS INHIBITION

H. Morris, P. Piper, P. Sirois, 1978, British journal of pharmacology.

Comparison of rat, mouse, guinea-pig and human slow reacting substance of anaphylaxis (SRS-A)

P. Piper, P. Sirois, E. G. Moore, 1979, Experientia.

Leukotrienes in airways and blood vessels.

P. Piper, 1989, Arzneimittel-Forschung.

Leukotrienes in the Lung and Cardiovascular System

N. Barnes, P. Piper, J. Costello, 1989 .

Inhibition of leukotriene release in anaphylactic guinea‐pig hearts by a 5‐lipoxygenase inhibitor, CGS 8515

P. Piper, H. Yaacob, 1988, British journal of pharmacology.

The combined use of isolated strips of guinea-pig lung parenchyma and ileum as a sensitive and selective bioassay for leukotriene B4.

P. Piper, M. N. Samhoun, 1984, Prostaglandins.

Actions and interactions of lipoxygenase and cyclo-oxygenase products in respiratory and vascular tissues.

P. Piper, M. N. Samhoun, 1984, Prostaglandins, leukotrienes, and medicine.

Generation of a leukotriene-like substance from porcine vascular and other tissues.

L. Letts, P. Piper, S. Galton, 1983, Prostaglandins.

[55] Preparation, purification, and structure elucidation of slow-reacting substance of anaphylaxis from guinea pig lung

H. Morris, G. Taylor, J. Tippins, 1982 .

Chapter 8. Slow-Reacting Substances

P. Piper, 1980 .

Slow-reacting substances and their structural elucidation.

H. Morris, G. Taylor, J. Tippins, 1980, Ciba Foundation symposium.

NON‐IMMUNOLOGICAL RELEASE OF SLOW‐REACTING SUBSTANCE FROM GUINEA‐PIG LUNGS

P. Piper, J. Seale, 1979, British journal of pharmacology.

Stimulation of arachidonic acid metabolism by human slow-reacting substances.

J. P. Seale, P. Piper, J. Seale, 1978, European journal of pharmacology.

The role of blood vessels in the bioconversion of leukotrienes in the pig

P. Piper, S. Galton, 1987, British journal of pharmacology.

THE EFFECT OF LEUKOTRIENE C4 ON MUCIN RELEASE INTO THE CAT TRACHEA in vivo AND in vitro

P. Piper, P. Richardson, A. C. Peatfield, 1982, British journal of pharmacology.

PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

P. Piper, D. Conroy, 2006 .

Slow reacting substance of anaphylaxis, SRS-A; assignment of the stereochemistry.

H. Morris, G. Taylor, J. Rokach, 1980, Prostaglandins.

Bradykinin‐Induced Responses of Human Bronchial Tissues

P. Piper, A. Bramley, 1991 .

Effect of a bradykinin B2 antagonist on responses of intact and rubbed guinea-pig trachea in vitro.

P. Piper, M. N. Samhoun, A. Bramley, 1989, British journal of pharmacology.

A possible role for leukotriene B4 in head and neck cancer.

J. Zakrzewski, J. Langdon, P. Piper, 1989, British Journal of Cancer.

A possible roleforleukotriene B4inheadandneckcancer

J. Zakrzewski, J. Langdon, P. Piper, 1989 .

The metabolism "in vitro" of leukotriene B4 in blood of normal subjects and asthmatic patients.

J. Zakrzewski, N. Barnes, A. Sampson, 1988, Prostaglandins.

Vasodilator actions of acetylcholine, A23187 and bradykinin in the guinea‐pig isolated perfused heart are independent of prostacyclin

A. Stewart, P. Piper, 1988, British journal of pharmacology.

Vasodilator actions ofacetylcholine, A23187and bradykinin intheguinea-pig isolated perfused heart areindependent ofprostacyclin

A. Stewart, P. Piper, 1988 .

Human eosinophil major basic protein augments bronchoconstriction induced by intravenous agonists in guinea pigs

G. Gleich, L. Letts, S. Desai, 2005, Agents and Actions.

Generation of leukotriene B4 and leukotriene E4 from porcine pulmonary artery.

P. Piper, S. Galton, 1984, Prostaglandins.

Atopic children with cystic fibrosis have increased urinary leukotriene E4 concentrations and more severe pulmonary disease.

P. Greally, J. Price, S. Chambers, 1994, The Journal of allergy and clinical immunology.

Detection ofsputum eicosanoids incystic fibrosis andinnormal saliva bybioassay andradioimmunoassay

J. Zakrzewski, N. Barnes, P. Piper, 1987 .

Comparative Effects of Leukotrienes in Respiratory Tissue of Various Species

N. Barnes, P. Piper, M. N. Samhoun, 1985 .

GENERATION OF LEUKOTRIENE B4, ITS ALL trans ISOMERS AND 5‐HYDROXYEICOSATETRAENOIC ACID BY RAT BASOPHILIC LEUKAEMIA CELLS

A. Ford-hutchinson, P. Piper, M. N. Samhoun, 1982, British journal of pharmacology.

COMPARATIVE STUDIES ON IMMUNOLOGICALLY AND NON‐IMMUNOLOGICALLY PRODUCED SLOW‐REACTING SUBSTANCES FROM MAN, GUINEA‐PIG AND RAT

H. Morris, G. Taylor, J. Tippins, 1979, British journal of pharmacology.

Release of slow-reacting substance from guinea-pig and human lung by calcium ionophore A23187 [proceedings].

J. P. Seale, P. Piper, J. Seale, 1978, British journal of pharmacology.

Effect of removing the endothelium on the vascular responses induced by leukotrienes C4 and D4 in guinea-pig isolated heart.

P. Piper, J. McLeod, 1992, European journal of pharmacology.

Studies of leukotriene antagonists and synthesis inhibitors in man.

J. Zakrzewski, N. Barnes, P. Piper, 1988, Progress in clinical and biological research.

The pharmacological profile of SK&F 104353-Z2, a potent, selective inhaled antagonist of cysteinyl leukotrienes, in normal man.

P. Piper, J. Costello, J. Evans, 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

A critical evaluation of the clinical relevance of leukotrienes in bronchial asthma.

J. Zakrzewski, N. Barnes, P. Piper, 1989, Agents and actions. Supplements.

CHAPTER III – Distribution and Metabolism

P. Piper, 1972 .

Bioassay and thin-layer chromatography of prostaglandins and their pulmonary metabolites [proceedings].

P. Piper, D. Crutchley, K. Crutchley, 1976, British journal of pharmacology.

CONDITIONS OF RELEASE OF PROSTAGLANDINS FROM THE LUNG

P. Piper, 1975 .

The release of rabbit aorta contracting substance (RCS) from chopped lung and its antagonism by anti-inflammatory drugs.

J. Vane, P. Piper, M. A. Palmer, 1970, British journal of pharmacology.

Release of vaso-active substances from lungs by injection of particles.

J. Vane, P. Piper, M. A. Palmer, 1970, British journal of pharmacology.

Interactions of anti-inflammatory steroids with PG system in adipose tissue.

P. Piper, G. Lewis, G. P. Lewis, 1978, Biochemical pharmacology.

Introduction to the biosynthesis and metabolism of prostaglandins.

P. Piper, 1977, Postgraduate medical journal.

Two sites of action of steroids on the prostaglandin system

P. Piper, G. Lewis, 1977 .

Leukotriene F4: Comparison of its pharmacological profile with that of the other cysteinyl-containing leukotrienes in guinea-pig ileum and lung parenchyma in vitro

P. Piper, M. N. Samhoun, 1984 .

Sputum leukotrienes and prostanoids - possible synergistic mediators in cyctic fibrosis, bronchiectasis or chronic bronchitis

J. Zakrzewski, N. Barnes, P. Piper, 1984 .

Pharmacological profile of leukotrienes E4, N-acetyl E4 and of four of their novel omega- and beta-oxidative metabolites in airways of guinea-pig and man in vitro.

P. Piper, D. Conroy, M. N. Samhoun, 1989, British journal of pharmacology.

Inulin as a marker of dilution of bronchoalveolar lavage in asthmatic and normal subjects.

L. Restrick, A. Sampson, P. Piper, 1995, American journal of respiratory and critical care medicine.

Leukotrienes: potent mediators of airway constriction.

P. Piper, 1985, International archives of allergy and applied immunology.

The nature of prostaglandin-like substances released from guinea-pig lung in anaphylaxis.

P. Piper, D. Crutchley, J. Seale, 1977, European journal of pharmacology.

Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids

P. Piper, G. Lewis, G. P. Lewis, 1975, Nature.

The release of spasmogenic substances from human chopped lung tissue and its inhibition

P. Piper, JOYCE L. Walker, J. Walker, 1973, British journal of pharmacology.

Arachidonic acid metabolism and SRS-A.

H. Morris, J. Tippins, P. Piper, 1979, Agents and actions. Supplements.

COMPARATIVE BIOASSAY OF PROSTAGLANDIN E2 AND ITS THREE PULMONARY METABOLITES

P. Piper, D. Crutchley, D.J. CRUTCHLEY, 1975, British journal of pharmacology.

The behaviour of the pulmonary metabolites of prostaglandins in several simple thin-layer chromatography and bioassay systems.

P. Piper, D. Crutchley, 1976, Prostaglandins.

INHIBITION OF THE PULMONARY INACTIVATION OF PROSTAGLANDINS in vivo BY DI‐4‐PHLORETIN PHOSPHATE

P. Piper, D. Crutchley, 1975, British journal of pharmacology.

The effect of arachidonate lipoxygenase substrates and inhibitors on SRS-A release in the guinea-pig lung [proceedings].

H. Morris, G. Taylor, J. Tippins, 1979, British journal of pharmacology.

Slow-reacting substance of anaphylaxis.

P. Piper, 1978, Annals of the Royal College of Surgeons of England.

Sputum cysteinyl‐leukotriene levels correlate with the severity of pulmonary disease in children with cystic fibrosis

C. P. Green, J. Price, P. Piper, 1992, Pediatric pulmonology.

The effects of two anti-CD18 antibodies on antigen-induced airway hyperresponsiveness and leukocyte accumulation in the guinea pig.

P. Piper, A. Milne, 1994, American Journal of Respiratory Cell and Molecular Biology.

Curtailment by aspirin and meclofenamate of hypotension induced by bradykinin in the guinea pig

P. Piper, L. Dinneen, A. Perkins, 2004, Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie.

Slow-reacting substances and their formation by a lipoxygenase pathway

H. Morris, G. Taylor, J. Tippins, 1980, Agents and Actions.

The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man.

N. Barnes, J Costello, N Barnes, 1987, The Journal of allergy and clinical immunology.

The effect of lipoxygenase inhibitors and diethylcarbamazine on the immunological release of slow reacting substance of anaphylaxis (SRS‐A) from guinea‐pig chopped lung

D. Temple, P. Piper, 1981, The Journal of pharmacy and pharmacology.

Actions of leukotrienes in special circulations of the pig.

P. Piper, A. Stanton, 1986, Advances in prostaglandin, thromboxane, and leukotriene research.

Inhibitors of nitric oxide synthase selectively reduce flow in tumour‐associated neovasculature

I. Hart, P. Piper, S. P. Andrade, 1992, British journal of pharmacology.

Effects of the released mediators of anaphylaxis on the target organs.

P. Piper, 1977, Scandinavian journal of respiratory diseases. Supplementum.

Leukotrienes in the cardiovascular system.

A. Sampson, P. Piper, H. Yaacob, 1988, Advances in prostaglandin, thromboxane, and leukotriene research.

Pharmacology and biochemistry of the leukotrienes.

P. Piper, 1982, European journal of respiratory diseases. Supplement.

Anaphylatoxin-induced shock and two patterns of anaphylactic shock: hemodynamics and mediators.

G. Smedegård, P. Piper, K. Pavek, 1979, Acta Physiologica Scandinavica.

The assay of catecholamines released into the circulation of the guinea-pig by angiotensin.

J. Vane, P. Piper, 1967, The Journal of physiology.

Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man.

P. Piper, J. Costello, D. Spencer, 1991, Thorax.

Structure elucidation and biosynthesis of slow reacting substances and slow reacting substance of anaphylaxis from guinea pig and human lungs

H. Morris, G. Taylor, Claire M. Jones, 1981 .

The distribution and mobilisation of arachidonic acid in fat cell ghosts and its modification by glucocorticoids [proceedings].

P. Piper, C. Vigo, G. P. Lewis, 1979, British journal of pharmacology.

Actions of leukotrienes on vascular, airway, and gastrointestinal smooth muscle.

L. Letts, J. Tippins, P. Piper, 1982, Advances in prostaglandin, thromboxane, and leukotriene research.